ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
92.88
-2.22 (-2.33%)
At close: Oct 2, 2026, 4:00 PM EDT
92.80
-0.08 (-0.09%)
After-hours: Oct 2, 2026, 7:44 PM EDT
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $8.19 billion as of October 2, 2026. Its market cap has increased by 29.98% in one year.
Market Cap
8.19B
Enterprise Value
7.74B
1-Year Change
29.98%
Ranking
Category
Stock Price
$92.88
ChartMarket Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $8.19B, an increase of 3,533.64%. That is a compound annual growth rate of 37.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 8.19B | -25.54% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Axsome Therapeutics | 9.54B |
| Kymera Therapeutics | 9.16B |
| Arrowhead Pharmaceuticals | 9.15B |
| Cytokinetics | 9.12B |
| Protagonist Therapeutics | 9.01B |
| Vaxcyte | 8.34B |
| Caris Life Sciences | 8.01B |
| Praxis Precision Medicines | 8.01B |